Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Shashank Sharma

Surgery Winchester, VA Medical Doctor

NPI 1225560642 CMS profile 11425817

1880 Amherst St Ste 300, Ste 300, Winchester, VA 22601

Open in the dashboard

General payments

$17,328

122 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Shashank Sharma of Winchester, VA is reported in the CMS Open Payments database as having received $17,328 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $168 3
2024 General $11,969 65
2023 General $4,755 47
2022 General $437 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Shashank Sharma
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Shashank Sharma were reported at $168. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Shashank Sharma Surgery median Middle half National median
2019 $0 $253 $82–$1,521 $163
2020 $0 $131 $40–$706 $114
2021 $0 $168 $50–$904 $132
2022 $437 $224 $76–$1,218 $149
2023 $4,755 $253 $82–$1,255 $160
2024 $11,969 $279 $90–$1,381 $164
2025 $168 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $13,711 79 payments
  2. Silk Road Medical, Inc. $1,486 14 payments
  3. Inari Medical, Inc. $565 5 payments
  4. W. L. Gore & Associates, Inc. $329 10 payments
  5. Terumo Medical Corporation $325 3 payments
  6. Medical Device Business Services, Inc. $305 1 payment
  7. Bolton Medical Inc $257 2 payments
  8. Kerecis Limited $187 1 payment
  9. Maquet Cardiovascular U.S. Sales, L.L.C. $32 1 payment
  10. Shape Memory Medical Inc. $26 1 payment
  11. Other $105 5 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Travel and Lodging $10,270 31 payments
  2. Food and Beverage $6,326 88 payments
  3. Education $666 2 payments
  4. Grant $67 1 payment
Products named General payments · program years 2022–2025
  1. ENDURANT IIS $10,904 55 payments
  2. Valiant Captivia $2,153 18 payments
  3. ENROUTE Transcarotid Stent $1,486 14 payments
  4. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,486 14 payments
  5. CT THROMBECTOMY SYSTEM KIT $565 5 payments
  6. FLOWTRIEVER CATHETER, S $565 5 payments
  7. Azur CX Detachable $457 4 payments
  8. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $444 5 payments
  9. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $444 5 payments
  10. NAVICROSS $325 3 payments
  11. Other $2,297 32 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Vascular Surgery: 122

Drug cost

$84

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 13 $84

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$60,541

Medicare's payments for the services billed

Medicare patients

339

Average age 75

Services billed

570

155 women, 184 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Ischemic heart disease 49%
Diabetes 41%
Chronic kidney disease 40%
COPD 34%
Heart failure 30%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record